SAP News Center

SAP, Roche and Tenthpin Partner to Create New Standard for Clinical Trial Supplies Operation

WALLDORF SAP SE (NYSE: SAP) and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that they, together with Tenthpin, are partnering to shape the future of clinical supplies operations and harmonize clinical and commercial supply chain management systems. The organizations have formed an industry consortium and are working together on the new, innovative, next-generation clinical trial supply management (CTSM) solution.

Organizations conducting clinical trials need visibility into demand to ensure supply and packaging availability, especially as the global pandemic impacts supply chains. To better address the specific needs of the life sciences clinical supplies practice, SAP, Roche and Tenthpin have initiated an industry consortium. This consortium consists of numerous stakeholders from the life sciences industry, including clinical trial and interactive response technology system vendors, and will focus on defining and orchestrating optimally aligned clinical supplies processes.

As part of the reimagined clinical supplies processes, SAP, together with its co-innovation customers, is designing a next-generation CTSM solution built on SAP S/4HANA and SAP’s industry cloud. This will address the specific blinding and randomization needs for clinical trials to facilitate demand forecasting, manufacturing, packaging, labeling and shipments of clinical trial materials. Together, SAP, Roche and Tenthpin address key priorities of the life sciences industry by enabling more accurate planning and better inventory management through the inclusion of clinical trial parameters, such as planned and active enrollment rates, into the supply and demand planning processes. The CTSM solution is planned to enable:

“This partnership represents a milestone in our industry cloud initiative,” said Peter Maier, president, Industries and Customer Advisory, SAP. “Together with Roche and Tenthpin, we can now address the specific needs of clinical trial supply management and improve business and ultimately patient outcomes. By gaining greater insights into forecasted demand and clinical site stock levels, the solution will help enable faster clinical supplies cycle times, reduce inventory overage and allow informed decision-making from start to finish.”

Learn more

Visit the SAP News Center. Follow SAP on Twitter at @SAPNews.

Media Contact:
Stacy Ries, +1 (484) 619-0411, stacy.ries@sap.com, ET
SAP Press Room; press@sap.com

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “should” and “will” and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
© 2020 SAP SE. All rights reserved.
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.

Exit mobile version